Skip to content

Search

Showing results for "Study of bullying"

Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response

SARS-CoV-2 nucleocapsid (N) protein antibodies can be used to identify the serological response to natural infection in those who have previously received a COVID-19 spike-based vaccine. Anti-N antibody responses can also be induced by inactivated whole SARS-CoV-2 virus vaccines, such as CoronaVac. We aimed to characterise antibody responses to the N protein following COVID-19 and following vaccination with CoronaVac.

Rural Cancer Siblings

We want to hear from siblings living outside of Australian cities!

WA Epithelial Research Program for Childhood Respiratory Diseases

Once thought to be a simple barrier to the external environment, epithelial cells are involved in many repair and inflammatory processes that occur in childhood airway diseases.

ORIGINS Enters the Shark Tank

ORIGINS Biobank Manager wins a Shark Tank pitch at Scientific Retreat

For Participants

Information for the 10,000 families participating in ORIGINS. Recruitment has now closed.

PCH Schools visit

Our head of epidemiology research Dr Aveni Haynes and exercise researcher Dr Wayne Soon were lucky enough to be invited to Perth Children’s Hospital School to discuss type 1 diabetes and the research we are doing here at the Children’s Diabetes Centre.

Celebrating our team

We thought we would share news of some fantastic achievements in our team recently.

Equipment available - PCH outpatient clinics

The Respiratory Physiology Platform at the Wal-yan Respiratory Research Centre offers access to specialist equipment housed within the outpatient research department at Perth Children’s Hospital, dedicated for research use.

Contact us

Please contact the team early (at the stage of project design and budgeting) to ensure the most appropriate physiological test is selected with adequate funding.